Impact of chronic rhinosinusitis on clinical presentation in patients with asthma

Y. Oshita, T. Koga, T. Kamimura, H. Aizawa (Kurume, Japan)

Source: Annual Congress 2006 - New aspects in the pathogenesis of asthma
Session: New aspects in the pathogenesis of asthma
Session type: Thematic Poster Session
Number: 1398
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Oshita, T. Koga, T. Kamimura, H. Aizawa (Kurume, Japan). Impact of chronic rhinosinusitis on clinical presentation in patients with asthma. Eur Respir J 2006; 28: Suppl. 50, 1398

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of adult rhinosinusitis on asthma severity
Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE
Year: 2012


Effects of therapy for rhinosinusitis in signs and symptoms of asthma in children
Source: Eur Respir J 2007; 30: Suppl. 51, 383s
Year: 2007

Effect of anti-IL5 treatment on symptoms of chronic rhinosinusitis, otitis and hearing loss in patients with severe eosinophilic asthma
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019


Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012

Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021


Characteristics and medication use of the patients with acute exacerbations of asthma-COPD overlap syndrome
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


Impact of omalizumab in patients with severe asthma
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009

Evaluation of physical sings and symptoms in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008

Acute severe asthma: evidence-based management of asthma exacerbations
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008



Characteristics of patients with persistent airflow obstruction from an asthma clinic
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013



The use of omalizumab in the management of severe chronic paediatric asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020


Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021



Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema
Source: Eur Respir J 2001; 17: 596-603
Year: 2001



Dupilumab improves patient-reported outcomes in chronic sinusitis with nasal polyps patients with comorbid asthma: Results from a phase 2a trial
Source: International Congress 2016 – Best abstracts in asthma and COPD
Year: 2016



Algorythm of differential diagnostics and further management of cough variant asthma in patients with chronic cough
Source: Eur Respir J 2003; 22: Suppl. 45, 372s
Year: 2003

Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018

Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016



Nocturnal respiratory symptoms in patients with chronic rhinosinusitis
Source: Annual Congress 2009 - Diagnostic aspects in obstructive sleep apnoea
Year: 2009


Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001